Serina Therapeutics, Inc.(SER)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SER Serina Therapeutics, Inc.

休市中 06-12 16:00:00 EDT

1.84

+0.03

+1.66%

盘后1.76

-0.08-4.35%

19:58 EDT

最高1.87	最低1.71	成交量16.19万
今开1.83	昨收1.81	日振幅8.73%
总市值2,760万	流通市值977.35万	总股本1,500万
成交额28.81万	换手率3.05%	流通股本531.17万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SER","market":"US","secType":"STK","nameCN":"Serina Therapeutics, Inc.","latestPrice":1.84,"timestamp":1781294400000,"preClose":1.81,"halted":0,"volume":161863,"hourTrading":{"tag":"盘后","latestPrice":1.76,"preClose":1.84,"latestTime":"19:58 EDT","volume":4199,"amount":7646.0213,"timestamp":1781308704506,"change":-0.08,"changeRate":-0.043478,"amplitude":0.108696},"delay":0,"changeRate":0.01657458563535913,"floatShares":5311700,"shares":14997505,"eps":-2.0109,"marketStatus":"休市中","change":0.03,"latestTime":"06-12 16:00:00 EDT","open":1.83,"high":1.87,"low":1.712,"amount":288108.75904720003,"amplitude":0.087293,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.0109,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1781510400000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":1.81,"preHourTrading":{"tag":"盘前","latestPrice":1.75,"preClose":1.75,"latestTime":"09:28 EDT","volume":16757,"amount":28942.3753684,"timestamp":1781270890732,"change":0,"changeRate":0,"amplitude":0.057143},"postHourTrading":{"tag":"盘后","latestPrice":1.76,"preClose":1.84,"latestTime":"19:58 EDT","volume":4199,"amount":7646.0213,"timestamp":1781308704506,"change":-0.08,"changeRate":-0.043478,"amplitude":0.108696},"volumeRatio":0.543326333338706},"requestUrl":"/m/hq/s/SER/wiki","defaultTab":"wiki","newsList":[{"id":"1169771277","title":"Serina Therapeutics公司提交文件，拟注册出售股东至多1650万股普通股的转售计划 - 美国证券交易委员会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1169771277","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169771277?lang=zh_cn&edition=full","pubTime":"2026-05-23 04:03","pubTimestamp":1779480194,"startTime":"0","endTime":"0","summary":"Serina Therapeutics公司已向美国证券交易委员会提交文件，申请注册由出售股东转售的至多1650万股普通股。此次备案旨在为现有股东的股份出售提供注册便利，使其能够在公开市场进行合规转让。根据提交的文件，拟转售的股份数量最高可达1650万股，具体出售时间、价格及数量将由相关股东根据市场情况自行决定。该注册声明生效后，相关股东即可根据声明条款在市场上出售其持有的公司普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137463093","title":"Serina Therapeutics：Ser-252针对晚期帕金森病的1B期注册研究已启动；关键数据目标定于2027年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1137463093","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137463093?lang=zh_cn&edition=full","pubTime":"2026-05-15 05:46","pubTimestamp":1778795203,"startTime":"0","endTime":"0","summary":"Serina Therapeutics公司宣布，其针对晚期帕金森病的研究性疗法Ser-252，其1B期注册研究现已启动。这项研究旨在评估该疗法的安全性与有效性，公司计划在2027年上半年获得关键数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182332459","title":"Serina Therapeutics完成3000万美元私募融资 推进帕金森病新药Ser-252注册临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1182332459","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182332459?lang=zh_cn&edition=full","pubTime":"2026-03-19 04:22","pubTimestamp":1773865345,"startTime":"0","endTime":"0","summary":"生物制药公司Serina Therapeutics宣布完成最高3000万美元的私募融资，所筹资金将主要用于推进其核心产品Ser-252治疗晚期帕金森病的注册临床试验。近期神经科学领域融资活动活跃，多家专注于阿尔茨海默病、帕金森病等神经系统疾病的新药研发公司相继获得大额融资。Serina Therapeutics此次融资成功，进一步印证了资本市场对解决未满足医疗需求的新型治疗方案的持续追捧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166056712","title":"Serina Therapeutics：预计2026年第三季度完成第一队列安全性及耐受性盲态评估并推进至第二队列","url":"https://stock-news.laohu8.com/highlight/detail?id=1166056712","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166056712?lang=zh_cn&edition=full","pubTime":"2026-02-25 05:51","pubTimestamp":1771969889,"startTime":"0","endTime":"0","summary":"Serina Therapeutics, Inc.宣布，针对其研究项目第一队列的盲态安全性及耐受性数据评估预计将于2026年第三季度完成。评估结束后，公司计划推进至第二队列的研究阶段。这一进展标志着项目按既定时间表顺利推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614078027","title":"Serina Therapeutics, Inc.盘中异动 早盘急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614078027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614078027?lang=zh_cn&edition=full","pubTime":"2026-02-25 00:15","pubTimestamp":1771949722,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日00时15分，Serina Therapeutics, Inc.股票出现异动，股价大幅上涨5.10%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段的生物技术公司，开发一系列全资拥有的候选药物产品，用于治疗神经系统疾病和疼痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602250015229541d83f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602250015229541d83f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612429794","title":"Serina Therapeutics, Inc.盘中异动 股价大涨6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612429794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612429794?lang=zh_cn&edition=full","pubTime":"2026-02-18 22:54","pubTimestamp":1771426476,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时54分，Serina Therapeutics, Inc.股票出现波动，股价急速上涨6.05%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段的生物技术公司，开发一系列全资拥有的候选药物产品，用于治疗神经系统疾病和疼痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218225437a7078332&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218225437a7078332&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SER","BK4007","BK4539","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611169875","title":"2期临床准备就绪，没钱只能无奈暂停","url":"https://stock-news.laohu8.com/highlight/detail?id=2611169875","media":"佰傲谷BioValley","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611169875?lang=zh_cn&edition=full","pubTime":"2026-02-13 12:30","pubTimestamp":1770957010,"startTime":"0","endTime":"0","summary":"2期临床准备就绪因没钱只能无奈暂停正是基于SER-155的1b期研究的积极结果，Seres公司决定大力推动SER-155的2期临床开发。至今，Seres公司已经完成了SER-155的2期临床研究的几乎所有关键准备工作，包括向FDA提交了最终临床方案、与CRO合作伙伴对研究站点进行了评估和资格认证、2期临床研究药物的生产制造。目前，SER-155用于免疫相关性结肠炎的临床已经全面注册，预计将于2026年第二季度初发布初步结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602131326309540ff27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602131326309540ff27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SER","LU1880383440.USD","BK1119","LU1880383366.USD","09927"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603760619","title":"Serina Therapeutics, Inc.盘中异动 早盘股价大涨5.69%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603760619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603760619?lang=zh_cn&edition=full","pubTime":"2026-01-15 00:11","pubTimestamp":1768407080,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日00时11分，Serina Therapeutics, Inc.股票出现异动，股价急速上涨5.69%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段的生物技术公司，开发一系列全资拥有的候选药物产品，用于治疗神经系统疾病和疼痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115001120a71aea3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115001120a71aea3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SER","LENZ","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601336095","title":"Serina Therapeutics, Inc.盘中异动 快速拉升6.01%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601336095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601336095?lang=zh_cn&edition=full","pubTime":"2026-01-08 01:31","pubTimestamp":1767807092,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日01时31分，Serina Therapeutics, Inc.股票出现波动，股价急速拉升6.01%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.09%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段的生物技术公司，开发一系列全资拥有的候选药物产品，用于治疗神经系统疾病和疼痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010801313397a13534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010801313397a13534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","BK4539","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194394501","title":"Serina Therapeutics任命Joshua Thomas博士为化学部副总裁，进一步加强管理团队","url":"https://stock-news.laohu8.com/highlight/detail?id=1194394501","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194394501?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:18","pubTimestamp":1765487911,"startTime":"0","endTime":"0","summary":"Serina Therapeutics任命Joshua Thomas博士为化学部副总裁，进一步加强管理团队","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155388366","title":"Serina Therapeutics, Inc. - 继续在澳大利亚开展场地启动和监管活动 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1155388366","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155388366?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:21","pubTimestamp":1765401714,"startTime":"0","endTime":"0","summary":"Serina Therapeutics, Inc. - 继续在澳大利亚开展场地启动和监管活动 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122510629","title":"Serina Therapeutics, Inc. - 提交针对FDA临床暂停信的完整回复，涉及Ser-252项目 - SEC报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1122510629","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122510629?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:20","pubTimestamp":1765401645,"startTime":"0","endTime":"0","summary":"Serina Therapeutics, Inc. - 提交针对FDA临床暂停信的完整回复，涉及Ser-252项目 - SEC报告","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516038266","title":"Serina Therapeutics, Inc.盘中异动 股价大跌6.28%报4.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516038266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516038266?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:12","pubTimestamp":1741101121,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时12分，Serina Therapeutics, Inc.股票出现波动，股价大幅跳水6.28%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231201abe7fbde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231201abe7fbde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SER","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512660681","title":"Serina Therapeutics, Inc.盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512660681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512660681?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:05","pubTimestamp":1739891102,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时05分，Serina Therapeutics, Inc.股票出现异动，股价快速上涨5.09%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Solid Biosciences Inc.、Allogene Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为333.24%、127.72%、119.52%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.，振幅分别为41.79%、34.04%、33.21%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230502a24ab443&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230502a24ab443&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SER","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511948626","title":"Serina Therapeutics, Inc.盘中异动 早盘大幅拉升8.56%报5.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511948626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511948626?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:13","pubTimestamp":1739546029,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时13分，Serina Therapeutics, Inc.股票出现异动，股价大幅上涨8.56%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2318.30%、605.57%、466.37%，振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.，振幅分别为66.93%、43.67%、40.35%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423134996232542&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423134996232542&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509249111","title":"Serina Therapeutics, Inc.盘中异动 股价大跌5.91%报4.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509249111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509249111?lang=zh_cn&edition=full","pubTime":"2025-02-05 05:00","pubTimestamp":1738702800,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日05时00分，Serina Therapeutics, Inc.股票出现波动，股价大幅下跌5.91%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.44%。其相关个股中，Mink Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1973.19%、998.32%、593.04%，振幅较大的相关个股有Azitra Inc、Mink Therapeutics, Inc.、Omega Therapeutics, Inc.，振幅分别为123.99%、80.03%、60.13%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205050000a2397027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205050000a2397027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508914257","title":"Serina Therapeutics, Inc.盘中异动 股价大涨5.11%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508914257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508914257?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:20","pubTimestamp":1738596029,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时20分，Serina Therapeutics, Inc.股票出现异动，股价快速拉升5.11%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.17%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为528.17%、409.28%、297.24%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为144.50%、75.23%、50.76%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203232029abc111ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203232029abc111ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508998137","title":"Serina Therapeutics, Inc.盘中异动 股价大涨5.33%报4.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508998137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508998137?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:16","pubTimestamp":1738343803,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日01时16分，Serina Therapeutics, Inc.股票出现异动，股价急速拉升5.33%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为2353.47%、1965.22%、188.87%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为80.00%、56.30%、53.03%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201011644abbe5869&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201011644abbe5869&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507620113","title":"Serina Therapeutics, Inc.盘中异动 早盘股价大涨6.26%报4.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507620113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507620113?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:09","pubTimestamp":1738249741,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时09分，Serina Therapeutics, Inc.股票出现波动，股价急速上涨6.26%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为1298.90%、171.61%、170.93%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited、Kazia Therapeutics Limited，振幅分别为56.41%、49.83%、42.03%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130230901a2345bd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130230901a2345bd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SER","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505104277","title":"Serina Therapeutics, Inc.盘中异动 早盘快速上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505104277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505104277?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:11","pubTimestamp":1737472268,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时11分，Serina Therapeutics, Inc.股票出现波动，股价急速拉升5.41%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Replimune Group, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为692.06%、204.72%、171.38%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation，振幅分别为92.63%、38.48%、22.36%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121231108a22a6072&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121231108a22a6072&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SER","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.serinatx.com","stockEarnings":[{"period":"1week","weight":-0.0213},{"period":"1month","weight":0.1795},{"period":"3month","weight":0.1871},{"period":"6month","weight":-0.4103},{"period":"1year","weight":-0.6895},{"period":"ytd","weight":-0.0382}],"compareEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.12},{"period":"6month","weight":0.088},{"period":"1year","weight":0.2286},{"period":"ytd","weight":0.0877}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Serina Therapeutics, Inc.于2017年1月在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，正在开发一系列全资候选药物，用于治疗神经系统疾病和其他适应症。该公司的POZ药物递送技术旨在使某些现有药物和新型候选药物能够进行修改，从而有可能提高包括小分子、基于RNA的疗法和基于抗体的药物偶联物在内的多种药物的综合疗效和安全性。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.123641},{"month":2,"riseRate":0.375,"avgChangeRate":-0.090531},{"month":3,"riseRate":0.625,"avgChangeRate":0.019814},{"month":4,"riseRate":0.375,"avgChangeRate":-0.064978},{"month":5,"riseRate":0.375,"avgChangeRate":-0.050188},{"month":6,"riseRate":0.625,"avgChangeRate":0.123816},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.044804},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.113434},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.1034},{"month":10,"riseRate":0.428571,"avgChangeRate":0.074812},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.13511},{"month":12,"riseRate":0.375,"avgChangeRate":-0.03882}],"exchange":"AMEX","name":"Serina Therapeutics, Inc.","nameEN":"Serina Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Serina Therapeutics, Inc.(SER)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Serina Therapeutics, Inc.(SER)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Serina Therapeutics, Inc.,SER,Serina Therapeutics, Inc.股票,Serina Therapeutics, Inc.股票老虎,Serina Therapeutics, Inc.股票老虎国际,Serina Therapeutics, Inc.行情,Serina Therapeutics, Inc.股票行情,Serina Therapeutics, Inc.股价,Serina Therapeutics, Inc.股市,Serina Therapeutics, Inc.股票价格,Serina Therapeutics, Inc.股票交易,Serina Therapeutics, Inc.股票购买,Serina Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Serina Therapeutics, Inc.(SER)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Serina Therapeutics, Inc.(SER)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}